login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
COHERUS ONCOLOGY INC (CHRS) Stock News
NASDAQ:CHRS -
US19249H1032
-
Common Stock
1.31
USD
-0.04 (-2.96%)
Last: 9/10/2025, 8:00:00 PM
1.32
USD
+0.01 (+0.76%)
After Hours:
9/10/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CHRS Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Benzinga
- Mentions:
CPRT
EAT
LDOS
DARE
This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
8 days ago - By: Coherus Oncology, Inc.
Coherus Oncology to Participate in Upcoming Investor Conferences
a month ago - By: The Motley Fool
Coherus (CHRS) Q2 Revenue Jumps 10%
a month ago - By: Zacks Investment Research
- Mentions:
FBIO
Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates
a month ago - By: Coherus Oncology, Inc.
Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
a month ago - By: Benzinga
- Mentions:
GSAT
PGY
ADV
REAL
...
Earnings Scheduled For August 7, 2025
a month ago - By: Coherus Oncology, Inc.
Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
a month ago - By: Zacks Investment Research
- Mentions:
RCUS
Arcus Biosciences, Inc. (RCUS) Reports Break-Even Earnings for Q2
a month ago - By: Coherus Oncology, Inc.
Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025
a month ago - By: Coherus Oncology, Inc.
Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025
3 months ago - By: Yahoo Finance
- Mentions:
ENB
VCYT
IART
NEM
...
Enbridge Is One of the Largest Energy Companies by Market Cap. But Is It a Buy?
3 months ago - By: Yahoo Finance
- Mentions:
VZ
ACOG
APLS
VRTX
...
Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory
3 months ago - By: Yahoo Finance
- Mentions:
VZ
JPM
ARGX
AXON
...
argenx SE (ARGX): A Bull Case Theory
3 months ago - By: Yahoo Finance
- Mentions:
VZ
ARGX
NFE
PLUG
...
Coherus BioSciences, Inc. (CHRS): A Bull Case Theory
3 months ago - By: Coherus Oncology, Inc.
Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics
4 months ago - By: Coherus BioSciences, Inc.
Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
4 months ago - By: Coherus BioSciences, Inc.
Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
4 months ago - By: Zacks Investment Research
- Mentions:
BRTX
Coherus BioSciences (CHRS) Reports Q1 Loss, Lags Revenue Estimates
4 months ago - By: Yahoo Finance
- Mentions:
APP
RLGT
ACMR
MNDY
...
AppLovin (APP): AI-Powered Axon Platform Fuels Earnings and E-Commerce Growth
4 months ago - By: Coherus BioSciences, Inc.
Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: Coherus BioSciences, Inc.
Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: Coherus BioSciences, Inc.
Coherus to Report First Quarter 2025 Financial Results on May 12, 2025
4 months ago - By: Coherus BioSciences, Inc.
Coherus to Report First Quarter 2025 Financial Results on May 12, 2025
4 months ago - By: Coherus BioSciences, Inc.
Coherus to Participate in Upcoming Investor Conferences
4 months ago - By: Coherus BioSciences, Inc.
Coherus to Participate in Upcoming Investor Conferences
5 months ago - By: Coherus BioSciences, Inc.
Coherus Presents Promising Early Clinical Data from Phase 1 Dose Expansion Study of CHS-114 in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at AACR 2025
5 months ago - By: Coherus BioSciences, Inc.
Coherus Presents Promising Early Clinical Data from Phase 1 Dose Expansion Study of CHS-114 in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at AACR 2025
5 months ago - By: Yahoo Finance
- Mentions:
JPM
Coherus divests Udenyca franchise to Intas for up to $558.4m
5 months ago - By: Coherus BioSciences, Inc.
Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise
5 months ago - By: Coherus BioSciences, Inc.
Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise
Please enable JavaScript to continue using this application.